HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

diphenyltin

Networked: 6 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Organometallic Compounds: 64
  - Organotin Compounds: 41
    - diphenyltin: 6

Experts

1.	Ge, Rui: 2 articles (04/2014 - 10/2013)
2.	Latif, Muhammad A M: 1 article (02/2019)
3.	Page, Alister J: 1 article (02/2019)
4.	Ravoof, Thahira B S A: 1 article (02/2019)
5.	Sakoff, Jennette A: 1 article (02/2019)
6.	Simone, Michela I: 1 article (02/2019)
7.	Tahir, Mohamed I M: 1 article (02/2019)
8.	Tiekink, Edward R T: 1 article (02/2019)
9.	Veerakumarasivam, Abhi: 1 article (02/2019)
10.	Yusof, Enis Nadia Md: 1 article (02/2019)

Related Diseases

1.	Neoplasms (Cancer) 10/30/2014 - "Preliminary in vitro cytotoxicity studies on five human tumor cells lines (HL-60, A549, HT-29, HCT-116 and Caco-2) by MTT assay reveal that di-n-butyltin(IV) complex 2 and diphenyltin(IV) complex 4 triggered significant antiproliferative effects in cultured tumor cells, and their cytotoxic activity correlates with intracellular organotin(IV) concentration. " 04/01/2014 - "Four diorganotin(IV) derivatives, dibutylbis[4-chloro-N-(hydroxy-<κ>O)benzamidato-<κ>O]tin(IV) (DBDCT), dibutylbis[2,6-difluoro-N-(hydroxy-<κ>O)benzamidato-<κ>O]tin(IV) (DBDFT), bis[2,4-difluoro-N-(hydroxy-<κ>O)benzamidato-<κ>O]diphenyltin(IV) (DPDFT), and bis[2,4-dichloro-N-(hydroxy-<κ>O)benzamidato-<κ>O]diphenyltin(IV) (DPDCT), were compared for their antitumor activity in vitro and in vivo along with their cytotoxic selectivity against human normal cells and cancer cells. "
2.	Pheochromocytoma 10/01/2013 - "The present study compared the cytotoxicity of three diorganotins, namely, dimethyltin (DMT), dibutyltin (DBT) and diphenyltin (DPT), in rat pheochromocytoma (PC12) cells, and the molecular mechanisms responsible for their cytotoxic effects were also explored. "
3.	Colorectal Neoplasms (Colorectal Cancer) 10/16/2023 - "In vitro anticancer activity of the synthesized diphenyltin(IV) complexes was evaluated against three human: MCF-7 (breast adenocarcinoma), A375 (melanoma), HCT116 (colorectal carcinoma), and three mouse tumor cell lines: 4T1 (breast carcinoma), B16 (melanoma), CT26 (colon carcinoma) using MTT and CV assays. "
4.	Experimental Melanoma 10/16/2023 - "In vitro anticancer activity of the synthesized diphenyltin(IV) complexes was evaluated against three human: MCF-7 (breast adenocarcinoma), A375 (melanoma), HCT116 (colorectal carcinoma), and three mouse tumor cell lines: 4T1 (breast carcinoma), B16 (melanoma), CT26 (colon carcinoma) using MTT and CV assays. "
5.	Melanoma (Melanoma, Malignant) 10/16/2023 - "In vitro anticancer activity of the synthesized diphenyltin(IV) complexes was evaluated against three human: MCF-7 (breast adenocarcinoma), A375 (melanoma), HCT116 (colorectal carcinoma), and three mouse tumor cell lines: 4T1 (breast carcinoma), B16 (melanoma), CT26 (colon carcinoma) using MTT and CV assays. "

Related Drugs and Biologics

1.	di-n-butyltin (dibutyltin)
2.	dimethyltin
3.	Tin